Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04458051 |
|---|---|
| Brief Title: | Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) (PERSEUS) |
| First Submitted : | July 1, 2020 |
| First Submitted that Met QC Criteria : | July 1, 2020 |
| First Posted : | July 7, 2020 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |